{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:13:42Z","timestamp":1764494022436},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jbspin.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T11:53:53Z","timestamp":1538826833000},"page":"459-466","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic hypercalcemia"],"prefix":"10.1016","volume":"86","author":[{"given":"Catherine","family":"Cormier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.10.001_bib0005","first-page":"2","volume":"19","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0010","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0020","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0025","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.jbspin.2018.10.001_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"Simonds","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2008.03408.x","volume":"70","author":"Caron","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0169","article-title":"Human chorionic gonadotropin measurements in parathyroid carcinoma","volume":"159","author":"Rubin","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"gcm2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0060","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1472-6823-14-81","article-title":"A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria","volume":"14","author":"Mastromatteo","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0070","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0080","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1210\/jc.2013-3593","article-title":"A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets","volume":"99","author":"Szczawinska","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0085","first-page":"2042","article-title":"Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2006-0857","article-title":"Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor","volume":"92","author":"Scillitani","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-09-0257","article-title":"Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager","volume":"161","author":"Brachet","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","article-title":"Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism","volume":"75","author":"Frank-Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4158\/EP11272.RA","article-title":"Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications","volume":"18","author":"Eldeiry","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2265.2010.03870.x","article-title":"Homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia","volume":"73","author":"Hannan","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0115","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"-Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0120","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: A follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.jbspin.2018.10.001_bib0130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/jc.2011-3082","article-title":"Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia","volume":"97","author":"Onuchic","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0135","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ando.2015.03.027","article-title":"Genetic evaluation in primary hyperparathyroidism: what investigation? For which patients?","volume":"76","author":"Groussin","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-3476(97)80029-7","article-title":"Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization","volume":"130","author":"Barcia","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2015.09.010","article-title":"Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted next generation sequencing","volume":"116","author":"Taillandier","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMc1206193","article-title":"Denosumab for post-transplantation hypercalcemia in osteopetrosis","volume":"367","author":"Shroff","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0165","first-page":"24","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial","volume":"16","author":"Hoyer-Kuhn","year":"2016","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","article-title":"Denosumab: an emerging therapy in pediatric bone disorders","volume":"4","author":"Boyce","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00223-016-0110-1","article-title":"Osteogenesis imperfecta type VI in individuals from Northern Canada","volume":"98","author":"Ward","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0180","first-page":"960","article-title":"Primary hyperparathyroidism in osteogenesis imperfecta","volume":"98","author":"Guay","year":"1968","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0185","first-page":"883","article-title":"The co-existence of primary hyperparathyroidism and osteogenesis imperfecta","volume":"108","author":"Salti","year":"1973","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF03343607","article-title":"Co-existence of osteogenesis imperfecta and hyperparathyroidism","volume":"22","author":"Zimmermann-Belsing","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.76.2.169","article-title":"Hypercalcaemia in osteogenesis imperfecta treated with pamidronate","volume":"76","author":"Williams","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0200","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2013-1143","article-title":"Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease","volume":"98","author":"Grasemann","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.10.001_bib0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in slc34a1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18303713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:14:53Z","timestamp":1559344493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18303713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1297319X18303713"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.10.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic hypercalcemia","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}